Naloxone for opioid-exposed newborn infants
- PMID: 30311212
- PMCID: PMC6517169
- DOI: 10.1002/14651858.CD003483.pub3
Naloxone for opioid-exposed newborn infants
Abstract
Background: Naloxone, a specific opioid antagonist, is available for the treatment of newborn infants with cardiorespiratory or neurological depression that may be due to intrauterine exposure to opioid. It is unclear whether newborn infants may benefit from this therapy and whether naloxone has any harmful effects.
Objectives: To determine the effect of naloxone on the need for and duration of neonatal unit stay in infants of mothers who received opioid analgesia prior to delivery or of mothers who have used a prescribed or non-prescribed opioid during pregnancy.
Search methods: We searched the following databases in February 2018: the Cochrane Central Register of Controlled Trials (the Cochrane Library 2018, Issue 1), MEDLINE (OvidSP), MEDLINE In process & Other Non-Indexed Citations (OvidSP), Embase (OvidSP), CINAHL (EBSCO), Maternity and Infant Care (OvidSP), and PubMed. We searched for ongoing and completed trials in the WHO International Clinical Trials Registry Platform and the EU Clinical Trials Register. We checked the reference lists of relevant articles to identify further potentially relevant studies.
Selection criteria: Randomised controlled trials comparing the administration of naloxone versus placebo, or no drug, or another dose of naloxone to newborn infants with suspected or confirmed in utero exposure to opioid.
Data collection and analysis: We extracted data using the standard methods of Cochrane Neonatal with separate evaluation of trial quality and data extraction by two review authors and synthesis of data using risk ratio, risk difference, and mean difference.
Main results: We included nine trials, with 316 participants in total, that compared the effects of naloxone versus placebo or no drug in newborn infants exposed to maternal opioid analgesia prior to delivery. None of the included trials investigated infants born to mothers who had used a prescribed or non-prescribed opioid during pregnancy. None of these trials specifically recruited infants with cardiorespiratory or neurological depression. The main outcomes reported were measures of respiratory function in the first six hours after birth. There is some evidence that naloxone increases alveolar ventilation. The trials did not assess the effect on the primary outcomes of this review (admission to a neonatal unit and failure to establish breastfeeding).
Authors' conclusions: The existing evidence from randomised controlled trials is insufficient to determine whether naloxone confers any important benefits to newborn infants with cardiorespiratory or neurological depression that may be due to intrauterine exposure to opioid. Given concerns about the safety of naloxone in this context, it may be appropriate to limit its use to randomised controlled trials that aim to resolve these uncertainties.
Conflict of interest statement
None.
Figures
Update of
-
Naloxone for opiate-exposed newborn infants.Cochrane Database Syst Rev. 2013 Feb 28;(2):CD003483. doi: 10.1002/14651858.CD003483.pub2. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2018 Oct 12;10:CD003483. doi: 10.1002/14651858.CD003483.pub3. PMID: 23450541 Updated.
References
References to studies included in this review
Bonta 1979 {published data only}
-
- Bonta BW, Gagliardi JV, Williams V, Warshaw JB. Naloxone reversal of mild neurobehavioral depression in normal newborn infants after routine obstetric analgesia. Journal of Pediatrics 1979;94(1):102‐5. [PUBMED: 363995] - PubMed
Brice 1979a {published data only}
Dick 1978a {published data only}
-
- Dick W, Knoche E, Traub E. Clinical investigations of the influence of various naloxone doses on the newborn. Journal of Perinatal Medicine 1978;6(2):95‐110. [PUBMED: 29088] - PubMed
Dick 1978b {published data only}
-
- Dick W, Knoche E, Traub E. Clinical investigations of the influence of various naloxone doses on the newborn. Journal of Perinatal Medicine 1978;6(2):95‐110. [PUBMED: 29088] - PubMed
Evans 1976 {published data only}
-
- Evans JM. The effect of naloxone on the early respiratory depressant effect of maternal pethidine analgesia. 4th European Congress of Anaesthesiology; 1974 Sep 5‐11; Madrid (Spain). New York (NY): Excerpta Medica, 1974.
-
- Evans JM, Hogg MI, Rosen M. The effect of naloxone on the depression of the early respiratory activity of neonates produced by maternal pethidine analgesia. In: Arias A editor(s). Recent Progress in Anaesthesiology and Resuscitation: IV European Congress of Anaesthesiology. Amsterdam: Excerpta Medica, 1975:72.
Gerhardt 1977 {published data only}
-
- Gerhardt T, Bancalari E, Cohen H, Rocha LF. Use of naloxone to reverse narcotic respiratory depression in the newborn infant. Journal of Pediatrics 1977;90(6):1009‐12. [PUBMED: 323443] - PubMed
-
- Gerhardt T, Bancalari E, Cohen H, Rocha LF, Holsinger K. Reversal of narcotic respiratory depression in the newborn with naloxone. American Society of Anesthesiologists Annual Meeting. Chicago, 1975.
Welles 1984 {published data only}
-
- Welles B, Belfrage P, Chateau P. Effects of naloxone on newborn infant behavior after maternal analgesia with pethidine during labor. Acta Obstetricia et Gynecologica Scandinavica 1984;63(7):617‐9. [PUBMED: 6516811] - PubMed
Wiener 1977a {published data only}
Wiener 1977b {published data only}
-
- Wiener PC, Hogg MI, Rosen M. Neonatal respiration, feeding and neurobehavioural state. Effects of intrapartum bupivacaine, pethidine and pethidine reversed by naloxone. Anaesthesia 1979;34(10):996‐1004. [PUBMED: 395854] - PubMed
References to studies excluded from this review
Brice 1979b {published data only}
-
- Brice JE, Moreland TA, Parija AC, Walker CH. Plasma naloxone levels in the newborn after intravenous or intramuscular administration. British Journal of Clinical Pharmacology 1979;8(4):412P‐3P. [PUBMED: 508546] - PubMed
Martin 1972 {published data only}
-
- Martin K, Knapstein PG, Melchert F, Schafer H, Tietze KW. Clinical experiences with the opiate antagonist naloxone in newborns [Klinische Erfahrungen mit dem Opiat‐Antagonisten naloxone beim Neugeborenen]. Tagung der Mittelrheinischen gesellschaft fur Geburtshilfe und Gynakologie 1972;143:10‐11.
Additional references
AAP 1980
-
- American Academy of Pediatrics Committee on Drugs. Naloxone use in newborns. Pediatrics 1980;65(3):667‐9. - PubMed
AAP 1990
-
- American Academy of Pediatrics Committee on Drugs. Naloxone dosage and route of administration for infants and children: addendum to emergency drug doses for infants and children. Pediatrics 1990;86(3):484‐5. [PUBMED: 2388800] - PubMed
AAP 1998
-
- American Academy of Pediatrics Committee on Drugs. Neonatal drug withdrawal. Pediatrics 1998;101(6):1079‐88. [PUBMED: 9614425] - PubMed
Burchell 2016
-
- Burchell T, Coster S, Norman I. The effect of intrapartum pethidine on breastfeeding: a scoping review. Evidence Based Midwifery 2016;14(2):49‐56.
De Castro 1993
-
- Castro RM, Cabral‐Filho JE, Costa JA, Costa FB, Gallindo MA, Hecksher CA. Neonatal treatment with naloxone causes permanent hyperalgesia in rats. Brazilian Journal of Medical & Biological Research 1993;26(7):747‐51. [PUBMED: 8268823] - PubMed
Gibbs 1989
-
- Gibbs J, Newson T, Williams J, Davidson DC. Naloxone hazard in infant of opioid abuser. Lancet 1989;2(8655):159‐60. [PUBMED: 2567922] - PubMed
Gill 2007
GRADEpro GDT [Computer program]
-
- GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed 15 March 2018. Hamilton (ON): GRADE Working Group, McMaster University, 2015.
Herschel 2000
-
- Herschel M, Khoshnood B, Lass NA. Role of naloxone in newborn resuscitation. Pediatrics 2000;106(4):831‐4. [PUBMED: 11015529] - PubMed
Higgins 2011
-
- Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.
Higgins 2017
-
- Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017. Available from training.cochrane.org/handbook.
James 2012
Jones 2012
Kattwinkel 2010
-
- Kattwinkel J, Perlman JM, Aziz K, Colby C, Fairchild K, Gallagher J, et al. Part 15: neonatal resuscitation: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010;122(18 Suppl 3):S909‐19: Erratum in: Circulation 2011;124(15):e406. [DOI: 10.1161/CIRCULATIONAHA.110.971119; PUBMED: 20956231] - DOI - PubMed
Kumar 2003
Lefebvre 2008
-
- Lefebvre C, Eisinga A, McDonald S, Paul N. Enhancing access to reports of randomized trials published world‐wide ‐ the contribution of EMBASE records to the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library. Emerging Themes in Epidemiology 2008;5:13. [DOI: 10.1186/1742-7622-5-13] - DOI - PMC - PubMed
Lefebvre 2011
-
- Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.
Lutz 2016
-
- Lutz TL, Elliott EJ, Jeffery HE. Sudden unexplained early neonatal death or collapse: a national surveillance study. Pediatric Research 2016;80(4):493‐8. [PUBMED: 27384403] - PubMed
Maas 1990
-
- Maas U, Kattner E, Weingart‐Jesse B, Schafer A, Obladen, M. Infrequent neonatal opiate withdrawal following maternal methadone detoxification during pregnancy. Journal of Perinatal Medicine 1990;18(2):111‐8. [PUBMED: 2366131] - PubMed
Mercer 2007
NICE 2017
-
- National Institute for Health and Care Excellence. Intrapartum care for healthy women and babies: Clinical Guideline CG190. www.nice.org.uk/guidance/cg190 (accessed 25 July 2018).
Niermeyer 2001
-
- Niermeyer S, Reempts P, Kattwinkel J, Wiswell T, Burchfield D, Saugstad OD, et al. International Liaison Committee on Resuscitation. Resuscitation of newborns. Annals of Emergency Medicine 2001;37(4 Suppl):S110‐25. [PUBMED: 11290975] - PubMed
Nissen 1995
-
- Nissen E, Lilja G, Matthiesen AS, Ransjo‐Arvidsson AB, Uvnas‐Moberg K, Widstrom AM. Effects of maternal pethidine on infants' developing breast feeding behaviour. Acta Paediatrica 1995;84(2):140‐5. [PUBMED: 7756797] - PubMed
Ogboli‐Nwasor 2014
Perlman 2010
-
- Perlman JM, Wyllie J, Kattwinkel J, Atkins DL, Chameides L, Goldsmith JP, et al. Neonatal Resuscitation Chapter Collaborators. Neonatal resuscitation: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Pediatrics 2010;126(5):e1319‐44. [DOI: 10.1542/peds.2010-2972B; PUBMED: 20956431] - DOI - PubMed
Perlman 2015
-
- Perlman JM, Wyllie J, Kattwinkel J, Wyckhoff MH, Aziz K, Guinsburg R, et al. Neonatal Resuscitation Chapter Collaborators. Part 7: Neonatal Resuscitation: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation 2015;132(16 Suppl 1):S204‐41. [DOI: 10.1161/CIR.0000000000000276; PUBMED: 26472855] - DOI - PubMed
Ransjo‐Arvidson 2001
-
- Ransjo‐Arvidson AB, Matthiesen AS, Lilja G, Nissen E, Widstrom AM, Uvnas‐Moberg K. Maternal analgesia during labor disturbs newborn behavior: effects on breastfeeding, temperature, and crying. Birth 2001;28(1):5‐12. [PUBMED: 11264622] - PubMed
Redshaw 2007
-
- Redshaw M, Rowe R, Hockley C, Brocklehurst P. Recorded delivery: a national survey of women's experience of maternity care 2006. www.npeu.ox.ac.uk/downloads/files/reports/Maternity‐Survey‐Report.pdf (accessed 24 July 2018).
RevMan 2014 [Computer program]
-
- Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Reynolds 2010
Schünemann 2013
-
- Schünemann H, Brożek J, Guyatt G, Oxman A, editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). gdt.guidelinedevelopment.org/app/handbook/handbook.html (accessed prior to 29 September 2018).
Smotherman 1992
-
- Smotherman WP, Robinson SR. Prenatal experience with milk: fetal behavior and endogenous opioid systems. Neuroscience & Biobehavioral Reviews 1992;16(3):351‐64. - PubMed
Szeto 1995
-
- Szeto HH, Soong Y, Wu DL, Cheng PY. Opioid modulation of fetal glucose homeostasis: role of receptor subtypes. Journal of Pharmacology and Experimental Therapeutics 1995;275(1):334‐9. [PUBMED: 7562568] - PubMed
References to other published versions of this review
McGuire 2002
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
